DEPARTMENT OF CLINICAL RESERCH (DCR)

The Department of Clinical Research (DCR) was started in 1994. Through its interaction with the Fundación de Investigaciones Metabólicas (F.I.M.) and international pharmaceutical laboratories, the DCR carries out research protocols on phase II, III and IV drugs administered to outpatients.

For IDIM staff, doing research is synonymous with commitment. With a historical population of almost 10,000 patients participating in our protocols, we have reached high levels of enrollment and very low  drop-out rates in the studies we have conducted, including those studies carried out for long periods of time. We are mainly involved in the following areas: metabolism, nutrition, lipids, osteology, diabetes mellitus, rheumatology.
Other research lines: gynecology and climacterium.

Principal Investigator: José R. Zanchetta, MD
Medical Director of Research: Fabio Massari, MD





HISTORICAL METRICS

First International Trial 1995
Number of trials since then 112
Number of trials On going now 9
Number of subjects screened 14410
Number of subjects randomized 8011
Average screening failure rate 48.3 %
Average drop out rate 20 % aprox.






SITE EVALUATION

Inspeccions: no major findings
Merck ANMAT Jun-2000
NPS Allelix corp ANMAT (2) 2003/2004
Wyeth ANMAT May-2004
Pfizer FDA May-2005
Pfizer EMEA Abril-2008
Radius Health ANMAT May-2009
Procter & Gamble FDA Abril-2010
Boehringer Ingelheim ANMAT Aug-2010
Janssen Cilag ANMAT Jun2011
Amgen ANMAT May/Jun-2014

Ethical Comitee Audits: 15 (no findings)

- Quality Assurance Audits: 38 (No major findings)
Sponsor

Amgen
AstraZeneca
Axovant
Eisai
Eli Lilly
F-Hoffmann - La Roche
Hoesch Marion Roussel
Macroflux
Merck Sharp & Dohme
Novartis
NPS Allelix Corp
Organon
Pfizer
Procter & Gamble
Radius
Sanofi / Aventis
Wyeth
Zodiac

CENTRAL DE TURNOS

(011) 5031-4100

IDIM CENTRO

Libertad 836

IDIM BELGRANO

Amenábar 1945

IDIM CABALLITO

Av. Rivadavia 5712

idim@idim.com.ar

BUSCAR

Haga click para buscar!